Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients

Transplantation

Volumn 96, Issue 9, 2013, Pages 843-849

  Bodro, Marta ^a   Sabé, Núria ^a   Tubau, Fe ^b   Lladó, Laura ^a   Baliellas, Carme ^a   Roca, Josep ^a   Cruzado, Josep Maria ^a   Carratalà, Jordi ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antimicrobial resistance; Bacteremia; ESKAPE; Outcomes; Solid organ transplantation

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BLOOD CULTURE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA; CONCURRENT INFECTION; DEREPRESSION CHROMOSOMIC BETA LACTAM AND EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTER; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FATALITY; FEMALE; HEART TRANSPLANTATION; HUMAN; INAPPROPRIATE PRESCRIBING; INTENSIVE CARE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ORGAN TRANSPLANTATION; PERSISTENT INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; QUINOLONE RESISTANT PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SEPTIC SHOCK; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; BACTERIAL INFECTIONS; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER; ENTEROCOCCUS FAECIUM; FEMALE; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; ORGAN TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; RISK FACTORS; YOUNG ADULT;

EID: 84888135080     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a049fd     Document Type: Article

References (46)

1. Moreno A, Cervera C, Gavalda J, et al. Bloodstream infections among transplant recipients: Results of a nationwide surveillance in Spain. Am J Transplant 2007; 7: 2579
2. Hsu RB, Chang CI, Fang CT, et al. Bloodstream infection in heart transplant recipients: 12-year experience at a university hospital in Taiwan. Eur J Cardiothorac Surg 2011; 40: 1362
3. Singh N, Wagener MM, Obman A, et al. Bacteremias in liver transplant recipients: Shift toward gram-negative bacteria as predominant pathogens. Liver Transplant 2004; 10: 844
4. Lee SO, Kang SH, Abdel-Massih RC, et al. Spectrum of early-onset and late-onset bacteremias after liver transplantation: Implications for management. Liver Transpl 2011; 17: 733
5. Singh N, Paterson DL, Gayowski T, et al. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000; 6: 54
6. Al-Hasan MN, Razonable RR, Eckel-Passow JE, et al. Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant 2009; 9: 835
7. Bert F, Larroque B, Paugam-Burtz C, et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: An analysis of 259 episodes. Liver Transpl 2010; 16: 393
8. Candel FJ, Grima E, Matesanz M, et al. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 2005; 37: 4097
9. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601
10. Shi SH, Kong HS, Xu J, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009; 11: 405
11. Linares L, Cervera C, Cofan F, et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 2007; 39: 2222
12. Kim YJ, Yoon JH, Kim SI, et al. High mortality associated with Acinetobacter species infection in liver transplant patients. Transplant Proc 2011; 43: 2397
13. Linares L, Cervera C, Hoyo I, et al. Klebsiella pneumoniae infection in solid organ transplant recipients: Epidemiology and antibiotic resistance. Transplant Proc 2010; 42: 2941
14. Herati RS, Blumberg EA. Losing ground: Multidrug-resistant bacteria in solid-organ transplantation. Curr Opin Infect Dis 2012; 25: 445
15. van Delden C, Blumberg EA. Multidrug resistant gram-negative bacteria in solid organ transplant recipients. Am J Transplant 2009; 9: S27
16. Paterson DL. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. Clin Infect Dis 2008; 47: S14
17. Rice LB. Progress and challenges in implementing the research on ESKAPE pathogens. Infect Control Hosp Epidemiol 2010; 31: S7
18. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J Infect Dis 2008; 197: 1079
19. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1
20. Sandiumenge A, Lisboa T, Gomez F, et al. Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms. Chest 2011; 140: 643
21. Sandiumenge A, Rello J. Ventilator-associated pneumonia caused by ESKAPE organisms: Cause, clinical features, and management. Curr Opin Pulm Med 2012; 18: 187
22. Gudiol C, Tubau F, Calatayud L, et al. Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: Risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 2011; 66: 657
23. Irfan S, Idrees F, Mehraj V, et al. Emergence of carbapenem resistant gram negative and vancomycin resistant gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study. BMC Infect Dis 2008; 8: 80
24. Giske CG, Monnet DL, Cars O, et al. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008; 52: 813
25. Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760
26. Joo EJ, Kang CI, Ha YE, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: Clinical impact of antimicrobial resistance on outcome. Microb Drug Resist 2011; 17: 305
27. Jung JY, Park MS, Kim SE, et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010; 10: 228
28. Muro S, Garza-Gonzalez E, Camacho-Ortiz A, et al. Risk factors associated with extended-spectrum beta-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: A clinical and molecular analysis. Chemotherapy 2012; 58: 217
29. Zhong L, Men TY, Li H, et al. Multidrug-resistant gram-negative bacterial infections after liver transplantation - Spectrum and risk factors. J Infect 2012; 64: 299
30. Ariza-Heredia EJ, Patel R, Blumberg EA, et al. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis 2012; 14: 229
31. Aznar J, Lepe JA, Dowzicky MJ. Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009). J Chemother 2012; 24: 74
32. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29: 996
33. Iida T, Kaido T, Yagi S, et al. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 2010; 16: 1379
34. Linares L, Garcia-Goez JF, Cervera C, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009; 41: 2262
35. Serefhanoglu K, Timurkaynak F, Arslan H, et al. Bacteremia among liver and kidney transplant recipients: Etiologic agents and antimicrobial susceptibilities. Braz J Infect Dis 2011; 15: 408
36. Rodriguez-Bano J, Picon E, Gijon P, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrumbeta- lactamase-producing Escherichia coli. J Clin Microbiol 2010; 48: 1726
37. Pena C, Gomez-Zorrilla S, Suarez C, et al. Extensively drug-resistant Pseudomonas aeruginosa: Risk of bloodstream infection in hospitalized patients. Eur J Clin Microbiol Infect Dis 2012; 31: 2791
38. Linares L, Cervera C, Cofan F, et al. Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gramnegative rods in renal transplantation. Am J Transplant 2008; 8: 1000
39. Rodriguez-Bano J, Navarro MD, Romero L, et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: Implications for control. Clin Infect Dis 2006; 42: 37
40. Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum betalactamase- producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089
41. Friedman ND, Kaye KS, Stout JE, et al. Health careYassociated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791
42. de la Torre-Cisneros J, Farinas MC, Caston JJ, et al. GESITRA-SEIMC/ REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin 2011; 29: 735
43. Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89: 779
44. Singh N, Husain S. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009; 9: S180
45. Bodro M, Sabe N, Gomila A, et al. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. Transplant Proc 2012; 44: 2682
46. Lee K, Lim YS, Yong D, et al. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallobeta- lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41: 4623